The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Compare

1 Followers

Luye Pharma Group (2186) Ownership Overview

1.95% Mutual Funds

2.18% ETFs

95.87% Public Companies and

Individual Investors

The ownership structure of Luye Pharma Group (HK:2186) stock is a mix of institutional, retail, and individual investors. , and 95.87% is owned by Public Companies and Individual Investors.

The ownership structure of Luye Pharma Group (HK:2186) stock is a mix of institutional, retail, and individual investors. Approximately 98.05% of the company’s stock is owned by Institutional Investors, 1.95% is owned by Insiders

Top Shareholders

# of Shares	Type	% Holding	Value
34,839,000	Institution	0.93%	10,277,505
30,812,231	Institution	0.82%	9,089,608
29,275,917	Institution	0.78%	8,636,396
26,601,039	Institution	0.71%	7,847,307
13,832,000	Institution	0.37%	4,080,440
6,490,000	Institution	0.17%	1,914,550
4,129,721	Institution	0.11%	1,218,268
2,320,284	Institution	0.06%	684,484
1,155,369	Institution	0.03%	340,834
1,137,500	Institution	0.03%	335,563

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
29,275,917	Institution	0.78%	8,636,396
26,601,039	Institution	0.71%	7,847,307
13,832,000	Institution	0.37%	4,080,440
1,155,369	Institution	0.03%	340,834
1,130,500	Institution	0.03%	333,498
526,500	Institution	0.01%	155,318
416,000	Institution	0.01%	122,720
249,500	Institution	<0.01%	73,603
189,500	Institution	<0.01%	55,903

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard FTSE Emerging Markets ETF	24,591,956	Institution	0.65%	6,845,848
iShares Core MSCI Emerging Markets ETF	17,564,000	Institution	0.47%	4,879,644
Avantis Emerging Markets Equity ETF	5,440,500	Institution	0.14%	1,511,484
Vanguard FTSE All-World ex-US Index Fund	3,817,961	Institution	0.10%	1,062,834
iShares Core MSCI Total International Stock ETF	2,912,500	Institution	0.08%	809,153
Schwab Emerging Markets Equity ETF	2,320,284	Institution	0.06%	643,551
SPDR S&P Emerging Markets Small Cap ETF	1,715,221	Institution	0.05%	475,731
SPDR Portfolio Emerging Markets ETF	1,256,500	Institution	0.03%	348,501
Dimensional Emerging Markets Value ETF	1,112,500	Institution	0.03%	308,562
iShares MSCI China Small-Cap ETF	1,004,500	Institution	0.03%	279,071

FAQ

Who Owns Luye Pharma Group Ltd. (HK:2186)?

Currently, no data Available

What percentage of Luye Pharma Group Ltd. (HK:2186) stock is held by institutional investors?

Currently, no data Available

What percentage of Luye Pharma Group Ltd. (HK:2186) stock is held by retail investors?

According to the latest TipRanks data, approximately 95.87% of Luye Pharma Group Ltd. (HK:2186) stock is held by retail investors.

Who owns the most shares of Luye Pharma Group Ltd. (HK:2186)?

iShares owns the most shares of Luye Pharma Group Ltd. (HK:2186).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing